The diagnostic and prognostic value of UBE2T in intrahepatic cholangiocarcinoma
Open Access
Abstract
Background: Ubiquitin-conjugating enzyme E2T (UBE2T) is overexpressed in several types of malignancies. However, little is known about its diagnostic significance in intrahepatic cholangiocarcinoma (ICC) and other bile duct diseases or its prognostic value in ICC. Methods: The expression levels of UBE2T in the intrahepatic bile duct (IHBD, N = 13), biliary intraepithelial neoplasia (BilIN; BilIN-1/2, N = 23; BilIN-3, N = 11), and ICC (N = 401) were examined by immunohistochemistry. The differential diagnostic and prognostic values were also assessed. Results: The number of UBE2T-positive cells was significantly higher in ICC tissues than in nonmalignant tissues, including the IHBD, BilIN-1/2, and BilIN-3 tissues. Kaplan–Meier analysis showed that overexpression of UBE2T was correlated with a shorter time to recurrence (TTR) and overall survival (OS). The 5-year TTR rates in the high UBE2T and low UBE2T groups were 100% and 86.2%, respectively. The corresponding OS rates were 1.9% and 22.2%, respectively. High expression of UBE2T was an independent risk factor for both TTR (hazard ratio: 1.345; 95% confidence interval: 1.047,1.728) and OS (hazard ratio: 1.420; 95% confidence interval: 1.098,1.837). Conclusions: UBE2T can assist in differentiating benign bile duct diseases from ICC, and high expression of UBE2T suggests a poor prognosis for ICC.Keywords
Funding Information
- National Natural Science Foundation of China (81972574, 81472769, 81472278)
- Mengchao Youth Talent Development Program
This publication has 37 references indexed in Scilit:
- UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinomaMolecular Medicine Reports, 2019
- Overexpression of MTHFD1 in hepatocellular carcinoma predicts poorer survival and recurrenceFuture Oncology, 2019
- Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic CholangiocarcinomaAnnals of Surgical Oncology, 2019
- Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resectionJournal of Hepatology, 2018
- Defining Long-Term Survivors Following Resection of Intrahepatic CholangiocarcinomaJournal of Gastrointestinal Surgery, 2017
- Neutrophils dominate the immune cell composition in non-small cell lung cancerNature Communications, 2017
- Loss of Secreted Frizzled-Related Protein-1 expression is associated with poor prognosis in intrahepatic cholangiocarcinomaEuropean Journal of Surgical Oncology, 2017
- UBE2T silencing suppresses proliferation and induces cell cycle arrest and apoptosis in bladder cancer cellsOncology Letters, 2016
- Intrahepatic Cholangiocarcinoma: expert consensus statementHPB, 2015
- Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial HepatectomyJournal of Clinical Oncology, 2013